Advertisement
Screener

EVOKE PHARMA, INC. Patents: Applications Rejected

EVOKE PHARMA, INC. Patent Applications Rejected

5 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-07-21: Application 17381464; Invention TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS; Applicant Evoke Pharma, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2020-03-11: Application 16646527; Invention METHODS OF INTRANASAL METOCLOPRAMIDE DOSING; Applicant Evoke Pharma, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2018-06-22: Application 16016246; Invention TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESIS; Applicant EVOKE Pharma, Inc; Status Abandoned -- Failure to Respond to an Office Action.
  • 2016-04-15: Application 15130086; Invention NASAL FORMULATIONS OF METOCLOPRAMIDE; Applicant Evoke Pharma, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2021-07-2117381464TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESISEvoke Pharma, Inc.Abandoned -- Failure to Respond to an Office ActionUS20220151960A1
Matthew J. D'ONOFRIO
David A. GONYER
Marilyn R. CARLSON
United States
United States
United States
FAY, ZOHREH ALEMZADEH
2020-03-1116646527METHODS OF INTRANASAL METOCLOPRAMIDE DOSINGEvoke Pharma, Inc.Abandoned -- Failure to Respond to an Office ActionUS20200276139A1
Marilyn R. CARLSON
Wayne ALVES
Matthew J. D'ONOFRIO
David A. GONYER
United States
United States
United States
United States
PALLAY, MICHAEL B
2018-06-2216016246TREATMENT OF SYMPTOMS ASSOCIATED WITH FEMALE GASTROPARESISEVOKE Pharma, IncAbandoned -- Failure to Respond to an Office ActionUS20190388370A1
Matthew J. D'ONOFRIO
David A. GONYER
Marilyn R. CARLSON
United States
United States
United States
QAZI, SABIHA NAIM
2016-04-1515130086NASAL FORMULATIONS OF METOCLOPRAMIDEEvoke Pharma, Inc.Abandoned -- Failure to Respond to an Office ActionUS20170071885A1
Matthew J. D'Onofrio
David A. Gonyer
Shirish A. Shah
Stuart J. Madden
United States
United States
United States
United States
LEE, WILLIAM Y
2012-10-2513660709NASAL FORMULATIONS OF METOCLOPRAMIDEEVOKE PHARMA, INC.Abandoned -- Failure to Respond to an Office ActionUS20130213393A1
Matthew J. D'Onofrio
David A. Gonyer
Shirish A. Shah
Stuart J. Madden
United States
United States
United States
United States
LEE, WILLIAM Y